Metraipolis › archive › dc_902fa06a993e
Emerging antiviral drugs and immunotherapy for chronic hepatitis B and associated liver disease — Europe PMC PMID:42233029
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42233029
- DOI
- 10.3389/fimmu.2026.1806527
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T05:17:31.451Z
- SHA-256 of the archived text
5ff84bc18593c74bba7b1f0b8f7349be9089422e4e66663869fee00a21f66eca- Stable URL of this page
https://metraipolis.com/documento/dc_902fa06a993e
How to cite
Emerging antiviral drugs and immunotherapy for chronic hepatitis B and associated liver disease — Europe PMC PMID:42233029 — Europe PMC (en), https://europepmc.org/article/MED/42233029 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_902fa06a993e (Metraipolis archive dc_902fa06a993e, sha256 5ff84bc18593c74bba7b1f0b8f7349be9089422e4e66663869fee00a21f66eca)
BibTeX
@misc{dc902fa06a993e,
title = {Emerging antiviral drugs and immunotherapy for chronic hepatitis B and associated liver disease — Europe PMC PMID:42233029},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42233029},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_902fa06a993e; sha256 5ff84bc18593c74bba7b1f0b8f7349be9089422e4e66663869fee00a21f66eca},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42233029. Agents can read the archived copy with the MCP tool read_document.